Full Text View
Tabular View
No Study Results Posted
Related Studies
Open-label Study With Bosentan in Interstitial Lung Disease (BUILD 2 OL)
This study has been completed.
Study NCT00319033   Information provided by Actelion

First Received on April 26, 2006.   Last Updated on February 11, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Interstitial Lung Disease
Scleroderma
Additional conditions recognized in this trial
Lung Diseases
Lung Diseases, Interstitial
Pulmonary Fibrosis
Scleroderma, Diffuse
Scleroderma, Systemic
More general conditions related to this trial
Connective Tissue Diseases
Respiratory Tract Diseases
Skin Diseases
Interventions listed in this trial
bosentan
More general drug interventions related to this trial
Antihypertensive Agents
Cardiovascular Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Actelion


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services